Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Intangibles (2021 - 2025)

Bioregenx (BRGX) has 5 years of Intangibles data on record, last reported at $725000.0 in Q3 2025.

  • For Q3 2025, Intangibles fell 92.5% year-over-year to $725000.0; the TTM value through Sep 2025 reached $725000.0, down 92.5%, while the annual FY2023 figure was $49363.0, 31.73% up from the prior year.
  • Intangibles reached $725000.0 in Q3 2025 per BRGX's latest filing, roughly flat from $725000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $18.6 million in Q1 2024 and bottomed at $33023.0 in Q3 2023.
  • Average Intangibles over 5 years is $3.6 million, with a median of $49363.0 recorded in 2023.
  • Peak YoY movement for Intangibles: soared 51447.68% in 2024, then plummeted 92.92% in 2025.
  • A 5-year view of Intangibles shows it stood at $43404.0 in 2021, then dropped by 13.66% to $37473.0 in 2022, then soared by 31.73% to $49363.0 in 2023, then surged by 19492.99% to $9.7 million in 2024, then crashed by 92.5% to $725000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Intangibles were $725000.0 in Q3 2025, $725000.0 in Q2 2025, and $9.7 million in Q3 2024.